COVID-19 vaccines: Open source licensing could keep Big Pharma from making huge profits off taxpayer-funded research
Governments must embrace policies that promote sharing and collective invention to create and distribute a vaccine quickly.
Sept. 18, 2020 • ~9 min
Tags: health medicine covid-19 pandemic vaccines sars-cov-2 open-source innovation-and-invention process-of-innovation
Using random testing, researchers in Indiana were able to calculate death rates by age, race, and sex and found sharp increases in risk of death among older and non-white state residents.
Sept. 10, 2020 • ~7 min
Tags: heart-disease health diabetes covid-19 coronavirus risk sars-cov-2 viruses indiana health-risks death-rate risk-of-death
UV disinfection is a proven means of killing pathogens like the SARS-CoV-2 virus, but it's not risk-free.
Sept. 9, 2020 • ~9 min
Tags: covid-19 coronavirus pandemic sars-cov-2 viruses aerosols disinfectant pathogen ultraviolet-light
A researcher explains what it will take to make sure children are reasonably safe from catching the coronavirus aboard school buses.
Sept. 3, 2020 • ~9 min
Tags: covid-19 sars-cov-2 coronavirus-2020 buses k-12-education transportation aerosols
Precision medicine is often touted as the future of medicine. But so far, it hasn't been helpful in the war against COVID-19. Here is how it could be used to tease apart the nuances of the disease.
Sept. 1, 2020 • ~8 min
Tags: genetics covid-19 pandemic sars-cov-2 precision-medicine
The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.
Sept. 1, 2020 • ~6 min
Tags: covid-19 coronavirus fda screening sars-cov-2 food-and-drug-administration testing viruses abbott emergency-use-authorization antigen-test pcr-testing covid-test
COVID-19 clues in a community's sewage: 4 questions answered about watching wastewater for coronavirus
Sewage surveillance is one technique that can alert authorities to the presence of a pathogen in the community. An environmental engineer explains the state of the science when it comes to SARS-CoV-2.
Aug. 31, 2020 • ~8 min
Tags: covid-19 coronavirus sars-cov-2 pathogens wastewater disease-surveillance
If antibody levels drop dramatically after an infection, what does that mean for immunity? An expert explains how B and T cells contribute to immunity and why antibodies don't tell the full story.
Aug. 26, 2020 • ~7 min
Tags: covid-19 immune-system pandemic sars-cov-2 adaptive-immune-response innate-immune-response immune-response t-cell antibody b-cell
Reports describe a Hong Kong man who was reinfected with the coronavirus after returning from Europe. Does that mean he wasn't immune after the first infection?
Aug. 25, 2020 • ~5 min
Tags: covid-19 coronavirus pandemic common-cold antibodies sars-cov-2 immunity viruses infection t-cell hong-kong
Approval of a coronavirus vaccine would be just the beginning – huge production challenges could cause long delays
Once a coronavirus vaccine is approved, billions of doses need to be manufactured. Current vaccine production is nowhere near ready, for a variety of reasons, but planning now could help.
Aug. 24, 2020 • ~11 min
Tags: covid-19 coronavirus manufacturing vaccines sars-cov-2 immunity herd-immunity viruses flu-vaccine pharma
Page 1 of 11